Dexcom, a maker of continuous glucose monitors, is developing a Type 2 diabetes monitor for those who don’t need insulin that has a 15-day sensor and a cash-pay option for patients not covered by Medicare and health insurers that want daily decision support.
With the number of diabetes-affected Americans numbering more than 37 million, according to the U.S. Centers for Disease Control, healthcare technology developers and researchers seek to…